| :: About Projects |
New vaccination therapies for lung cancer
Start date:2004-10-01
End date:2006-09-30
Project Acronym:LCVAC
Project status:Completed
Coordinator
| Organization name:MUBIO PRODUCTS BV | |
| Administrative contact | Address |
|
Name:Stefan |
MUBIO PRODUCTS BV PO Box 1091 Oxfordlaan 70 MAATRICHT NEDERLAND Region: |
| Tel:+31-433885804 | |
| Fax:+31-433258183 | |
| E-mail:Contact | |
| URL: | Organization Type:Industry |
Description
Objective:
The aim of this project is to develop new vaccination approaches for the highly needed treatment of lung cancer. Lung carcinoma is the number one killer amongst cancer patients, for which no adequate treatment exists. With conventional therapy, median survival for the subtype of small cell lung cancer (SCLC) is 15 months for limited-stage disease and 9 months for extensive-stage disease, whereas long-term survival is very low.
Major obstacles to the successful treatment and eradication of lung cancer are late diagnosis, highly metastatic behaviour, resistance to chemotherapy and the impossibility to surgically remove all cancer cells. In principle, cancer vaccines are a most promising approach for the treatment of cancer in general and lung cancer in particular. Major obstacles in the development of a successful vaccine are the lack of cancer specific antigens to be targeted and the lack of tools to evaluate immunotherapy based on such targets.
Achievements:
General information:
Project Details
Start date:2004-10-01
End date:2006-09-30
Duration:24 months
Project Reference:512855
Project cost:1763349 EURO
Project Funding:1231269 EURO
Programme Acronym:
FP6-SME
Programme type:Sixth Framework Programme
Subprogramme Area:Horizontal research activities involving SMEs
Contract type:SMEs-Co-operative research contracts
URL:
Subject index:Regional Development, Economic Aspects
Results for this Project
| Final Report Summary - LCVAC (New vaccination therapies for lung cancer) | 14/04/2011 |
Documents for this Project
| Final Report - LCVAC (New vaccination therapies for lung cancer) | 14/04/2011 |
Other participants
| Organization name:CIRES GMBH | |
| Administrative contact | Address |
|
Name:Frank Walter |
CIRES GMBH Emil-Figge Strasse 76A DORTMUND DEUTSCHLAND Region:NORDRHEIN-WESTFALEN ARNSBERG Dortmund, Kreisfreie Stadt |
| Tel:+49-231-9742880 | |
| Fax:+49-231-9742881 | |
| E-mail: | |
| URL:http://Contact | Organization Type:Industry |
| Organization name:ONYVAX LIMITED | |
| Administrative contact | Address |
|
Name:Pantelli |
ONYVAX LIMITED St. Georges Hospital Medical School, Cranmer Terrace LONDON UNITED KINGDOM Region:SOUTH EAST (UK) GREATER LONDON |
| Tel:+44-2086829122 | |
| Fax:+44-2086829495 | |
| E-mail:Contact | |
| URL:http://www.onyvax.com | Organization Type:Industry |
| Organization name:MEDICAL PROTEOM- CENTER, RUHR-UNIVERSITY BOCHUM | |
| Administrative contact | Address |
|
Name:Kai |
MEDICAL PROTEOM-CENTER (MPC), RUHR-UNIVERSITY BOCHUM Universitaetsstrasse 150 BOCHUM DEUTSCHLAND Region:NORDRHEIN-WESTFALEN ARNSBERG Bochum, Kreisfreie Stadt |
| Tel:+49-2343227083 | |
| Fax:+49-2343214554 | |
| E-mail:Contact | |
| URL:http://www.medizinisches-proteom-center.de | Organization Type: |
| Organization name:UNIVERSITEIT MAASTRICHT/RESEARCH INSTITUTE GROWTH & DEVELOPMENT | |
| Administrative contact | Address |
|
Name:Frans C.S. |
DEPT.MOLECULAR CELL BIOLOGY- FACULTY OF MEDICINE-RESEARCH INSTITUTE GROW PO Box 616 Universiteitssingel 50 MAASTRICHT NEDERLAND Region:ZUID-NEDERLAND LIMBURG (NL) Zuid-Limburg |
| Tel:+31-0433881351 | |
| Fax:+31-0433884151 | |
| E-mail:Contact | |
| URL:http://www.grow.unimaas.nl | Organization Type: |
Record control number:86544
